Full-Time

Applications Scientist

Confirmed live in the last 24 hours

Schrödinger

Schrödinger

501-1,000 employees

Computational platform for biopharmaceutical research

Government & Public Sector
Enterprise Software
Biotechnology

Compensation Overview

$120k - $160kAnnually

Senior, Expert

San Diego, CA, USA

Hybrid workweeks expected.

Category
Computational Biology
Biology Lab & Research
Biology & Biotech
Required Skills
Python
Requirements
  • PhD in computational chemistry or a related field
  • Post-doctoral research and/or relevant experience in the life-science commercial sector
  • Fluency in both English and Mandarin are required
  • Willingness to work flexible hours, in order to maximize the overlap between US Pacific and China business hours
  • Ability and willingness to travel to China on at least a quarterly basis, or as required
  • A solid understanding of the commercial drug discovery process
  • Experience in one of the following: molecular dynamics simulations/enhanced sampling/free energy calculation methods, ligand-based drug design, quantum mechanics, and/or structural modeling
  • Programming experience (preferably Python) is a plus
  • Medicinal chemistry knowledge is a plus
Responsibilities
  • Provide scientific support to current and prospective life-science customers based in China, which includes demonstrating the optimal use of our life science software suites, facilitating interactions between customers and product development teams, and providing general scientific guidance
  • Engage in cutting edge scientific research to continuously develop personal expertise and establish best practices for customers
  • Work cross-functionally with Product Managers, Account Managers and the Marketing team to improve business strategies
  • Publish scientific papers and present at conferences

Schrödinger provides a computational platform that aids in the research efforts of biopharmaceutical companies, academic institutions, and government laboratories around the world. Their platform offers advanced computational tools that help in drug discovery and research across various therapeutic areas. Schrödinger's products work by utilizing sophisticated algorithms and simulations to predict molecular behavior, which assists researchers in understanding how different compounds can affect biological systems. What sets Schrödinger apart from its competitors is its extensive global reach, serving clients in over 70 countries, and its dual focus on both software licensing and collaborative drug discovery programs. The company's goal is to advance scientific research and innovation by providing powerful tools and services that enhance the drug discovery process.

Company Stage

IPO

Total Funding

$362.7M

Headquarters

New York City, New York

Founded

1990

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • $19.5M Gates Foundation grant boosts research in neglected diseases, expanding R&D opportunities.
  • $10M grant supports predictive toxicology tools, reducing drug development failures.
  • Schrödinger's platform efficiently explores chemical space, accelerating drug candidate identification.

What critics are saying

  • Recursion and Exscientia merger creates a strong competitor in AI-driven drug discovery.
  • Avicenna's independent expansion could lead to competitive tensions with Schrödinger.
  • Reliance on grants like Gates Foundation funding poses financial sustainability risks.

What makes Schrödinger unique

  • Schrödinger's platform supports diverse clients, including biopharmaceuticals and academic institutions globally.
  • The company excels in rapid drug discovery, exemplified by SGR-1505's swift development.
  • Schrödinger's collaboration with Avicenna enhances medicinal chemistry through machine learning.

Help us improve and share your feedback! Did you find this helpful?